PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 79 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $311,000 | -95.5% | 25,000 | -88.8% | 0.00% | -100.0% |
| Q3 2021 | $6,950,000 | +870.7% | 222,400 | +789.6% | 0.00% | – |
| Q2 2021 | $716,000 | -33.9% | 25,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,083,000 | -24.3% | 25,000 | +25.0% | 0.00% | – |
| Q4 2020 | $1,431,000 | +137.3% | 20,000 | 0.0% | 0.00% | – |
| Q3 2020 | $603,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $41,564,265 | 0.82% |
| Boxer Capital, LLC | 2,568,287 | $9,785,173 | 0.52% |
| Baker Brothers Advisors | 10,123,824 | $38,571,769 | 0.49% |
| Sio Capital Management, LLC | 320,394 | $1,220,701 | 0.33% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,133,000 | $15,746,730 | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 123,600 | $470,916 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 48,727 | $185,650 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 18,839 | $71,777 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11,074 | $42,192 | 0.00% |
| KENNEDY CAPITAL MANAGEMENT LLC | 35,283 | $134,428 | 0.00% |